It's not the first therapy in the oncolytic virus class to be approved ... with results to date indicating that direct injection into the tumour is well tolerated with no severe adverse effects.

ReiThera is proud to announce a new partnership with SillaJen through a comprehensive Master Service Agreement (MSA), which establishes ReiThera as the manufacturing partner for SillaJen’s innovative ...

Oncolytic viruses (OVs) are viruses that infect and kill cancer cells while sparing healthy tissue, making them a promising therapeutic option in cancer ...

These names in the biotech sector are seeing a substantial increase in search activity today, as determined by InvestingChannel. They ...

creating simpler treatment options is seen as the main way to make progress. Various companies are trying to develop intramuscular injections, subcutaneous injections, infusions, implants, patches and ...

When getting preventative botox, you can expect a similar process as getting regular Botox ... and to avoid working for about 48 hours post-injection. While most will start to notice the ...

To counteract these challenges, novel strategies aim to restore the cancer immunity cycle. One approach involves directly injecting unadjuvanted influenza vaccines or drug-loaded oncolytic viruses ...

EP: 6.Patient Experiences, Key Clinical Trial Outcomes of the Port Delivery System ...

Learn about the benefits, applications, and best practices of robotics in injection molding, and how they can improve productivity, quality, and flexibility. Agree & Join LinkedIn ...

To address these limitations of DC as immunotherapeutic agent, we have developed a polymeric nanocomplex incorporating (1) oncolytic adenovirus (oAd ... Furthermore, oAd/APP+DC treatment led superior ...